MK-3903
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


MK-3903
Description:
MK-3903 is a potent and selective AMP-activated protein kinase (AMPK) activator with an EC50 of 8 nM.UNSPSC:
12352005Hazard Statement:
H302-H315-H319-H335Target:
AMPKType:
Reference compoundRelated Pathways:
Epigenetics; PI3K/Akt/mTORApplications:
Metabolism-sugar/lipid metabolismField of Research:
Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/MK-3903.htmlPurity:
98.03Solubility:
DMSO : ≥ 100 mg/mLSmiles:
ClC1=CC2=C (NC (OC3=CC=C (C) C (C (O) =O) =C3) =N2) C=C1C (C=C4) =CC=C4C5=CC=CC=C5Molecular Formula:
C27H19ClN2O3Molecular Weight:
454.90Precautions:
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501References & Citations:
[1]Lan P, Romero FA, et al. Hit-to-Lead Optimization and Discovery of 5- ((5- ([1,1'-Biphenyl]-4-yl) -6-chloro-1H-benzo[d]imidazol-2-yl) oxy) -2-methylbenzoic Acid (MK-3903) : A Novel Class of Benzimidazole-Based Activators of AMP-Activated Protein Kinase. J Med Chem. 2017 Nov 9;60 (21) :9040-9052.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
AMPKCAS Number:
1219737-12-8
